Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom clinical extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1824831000000117 | Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom clinical extension module |
1824841000000114 | Administration of 9vHPV (9-valent Human papillomavirus) vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom clinical extension module |
1824851000000112 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (procedure) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom clinical extension module |
1824881000000118 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom clinical extension module |
1824891000000116 | Administration of HPV (Human papillomavirus) 9-valent vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom clinical extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens | Is a | Administration of vaccine product containing only Human papillomavirus antigen | false | Inferred relationship | Existential restriction modifier | ||
Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens | Is a | Administration of vaccine product containing virus antigen | false | Inferred relationship | Existential restriction modifier | ||
Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens | Is a | Administration of vaccine product containing only Human papillomavirus antigen | false | Inferred relationship | Existential restriction modifier | ||
Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens | Direct substance | Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) | false | Inferred relationship | Existential restriction modifier | 1 | |
Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens | Method | Administration - action | false | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets